Lindsay Davies Email & Phone Number | With a strong background in translational stem and stromal cell biology research, I have recently transitioned into industry, founding CellTherEx Consulting and commencing my position as Chief Scientific Officer and Business Developer at NextCell Pharma AB. These roles have provided me with the opportunity to focus on my drive to see novel therapies move into the clinic and benefit patients. I have also been able to maintain my academic links to the field of stromal cell biology and am affiliated to Karolinska Institutet, where I continue to enjoy links to my ongoing research in oral progenitor cell biology, mesenchymal stromal cell therapy and their potential in wound healing and treatment of immune-mediated disorders. I am passionate about advanced therapy development and seeing improved accessibility of new drug products to patients in need. In support of this, in addition to my scientific, consultancy and board roles I am actively involved in a number of Swedish and International initiatives in the advanced therapy community. My recent appointment as Regional Secretary for the International Society of Cell and Gene Therapy and industry representative for the Swedish National Coordination Group for ATMPs are examples of this.

Lindsay Davies

With a strong background in translational stem and stromal cell biology research, I have recently tr...
Nextcell Pharma, Sweden, Sweden

*50 free lookup(s) per month.

Lindsay Davies’s Email lindsay.davies@ki.se

Lindsay Davies’s Phone Numbers

Get LINDSAY’s Phone Number (For Free)

Social Media

Lindsay Davies’s Location Nextcell Pharma, Sweden, Sweden

Lindsay Davies’s Current Industry Isct International Society For Cell And Gene Therapy Nextcell Pharma Karolinska Institutet Celltherex Consulting

Lindsay Davies’s Prior Industry Finnish Red Cross Blood Service | Cardiff University

Find accurate emails & phone numbers for over 700M professionals.

European Regional Secretary

2023-06-01 00:00:00 - Present

Chief Scientific Officer

2020-06-01 00:00:00 - Present

Affiliated Researcher

2020-03-01 00:00:00 - Present

Chief Executive Officer and Founder

2020-03-01 00:00:00 - Present

Medical Device Development Specialist

2018-06-01 00:00:00 - 2019-03-01 00:00:00

Research Group Leader and Lecturer in Stem Cell Immunology

2013-02-01 00:00:00 - 2014-08-01 00:00:00

No Skills Available

No Languages Available

Lindsay Davies is a With a strong background in translational stem and stromal cell biology research, I have recently transitioned into industry, founding CellTherEx Consulting and commencing my position as Chief Scientific Officer and Business Developer at NextCell Pharma AB. These roles have provided me with the opportunity to focus on my drive to see novel therapies move into the clinic and benefit patients. I have also been able to maintain my academic links to the field of stromal cell biology and am affiliated to Karolinska Institutet, where I continue to enjoy links to my ongoing research in oral progenitor cell biology, mesenchymal stromal cell therapy and their potential in wound healing and treatment of immune-mediated disorders. I am passionate about advanced therapy development and seeing improved accessibility of new drug products to patients in need. In support of this, in addition to my scientific, consultancy and board roles I am actively involved in a number of Swedish and International initiatives in the advanced therapy community. My recent appointment as Regional Secretary for the International Society of Cell and Gene Therapy and industry representative for the Swedish National Coordination Group for ATMPs are examples of this.

Lindsay Davies currently works in the Isct International Society For Cell And Gene Therapy | Nextcell Pharma | Karolinska Institutet | Celltherex Consulting |

Lindsay Davies has prior
experience in the following industries:
Finnish Red Cross Blood Service | Cardiff University

Lindsay Davies has the following professional experience:
Isct International Society For Cell And Gene Therapy | Nextcell Pharma | Karolinska Institutet | Celltherex Consulting | Finnish Red Cross Blood Service | Cardiff University